The Russian Direct Investment Fund says it has 20 technology transfer and production agreements in place in 13 countries across the world.
Production of the Russian Sputnik V vaccine is now under way in Argentina and Serbia following the signing of technology transfer and production agreements. Similar deals are in place in 11 other countries, according to the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, which is financing the development of the vaccine.
Production in both countries began on 4 June. In Argentina, local company Richmond Laboratories is manufacturing the vaccine, which will...
<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>
As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.
<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.
